Security key
00887A204
Rein Therapeutics, Inc. - Common Stock, $0.001 par value per share (RNTX)
CUSIP: 00887A204
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 1,063,685
- Total 13F value
- $3,241,840
- Share change
- +40,465
- SEC-reported price per share
- $3.05
- Number of holders
- 19
- Value change
- +$183,775
- Number of buys
- 10
- Number of sells
- 4
- Shares outstanding
- 84,905,660
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
19
Top holders
10
RNTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Rein Therapeutics, Inc. SEC filings
Rein Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00887A204
Recent filing periods:
Ownership snapshot
Top reported holders of RNTX - Rein Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Alerce Investment Managem...
Disclosed value leader
Alerce Investment Managem...
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 0.98%
Showing 1-6 of 15 holder rows.
Quick read
Alerce Investment Management, L.P. leads the comparable SEC ownership view at 0.98%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Alerce Investment Management, L.P.'s linked filing trail.
Comparable ownership
Top 5
Alerce Investment Management, L.P.
0.98%
GEODE CAPITAL MANAGEMENT, LLC
0.07%
VANGUARD GROUP INC
0.05%
BLAIR WILLIAM & CO/IL
0.03%
KCK LTD.
0.03%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Alerce Investment Management, L.P. |
13F
Company
|
0.98%
|
$1,262,308
830,466 shares
|
— | 30 Sep 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.07%
|
$85,334
56,513 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
0.05%
|
$60,700
39,934 shares
|
— | 30 Sep 2023 |
| BLAIR WILLIAM & CO/IL |
13F
Company
|
0.03%
|
$44,075
28,997 shares
|
— | 30 Sep 2023 |
| KCK LTD. |
13F
Company
|
0.03%
|
$33,958
22,341 shares
|
— | 30 Sep 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.02%
|
$30,434
20,155 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
1,063,685
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q1 2026 Across Filers
Q1 2026 holders
45
Q4 2023 holders
19
Holder diff
-26
| Investor | Q1 2026 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q1 2026 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend